arrow_backBack to Catalogue
Bioregulator
Cartalax
Targeted cartilage and bone bioregulator for joint health.
Clinical Profile
- check_circlePromotes joint and cartilage repair
- check_circleSupports bone density and resilience
- check_circleReduces age-related connective tissue thinning
- check_circleEnhances mobility and joint comfort
biotech
Mechanism of Action
A three-amino acid peptide that modulates the metabolism of cartilage cells (chondrocytes). It promotes the synthesis of collagen and other essential proteins within the joint matrix, supporting overall skeletal system integrity.
medication_liquid
Therapeutic Application
Typically used in 4-6 week cycles to support joint and connective tissue health.
Ready to include Cartalax in your protocols?
Log in to the prescriber portal to access research monographs, inventory availability, and peer-reviewed clinical studies.